Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Acamprosate + Mefloquine
|
DCK9UEK
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Acetazolamide + Mefloquine
|
DC01VCC
|
Acetazolamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Alfacalcidol + Mefloquine
|
DCBA29L
|
Alfacalcidol
|
DD2 (Cell Line: DD2)
|
[5] |
Aliskiren + Mefloquine
|
DCZSCP5
|
Aliskiren
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Allopurinol + Mefloquine
|
DCYD7VL
|
Allopurinol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Amantadine + Mefloquine
|
DCU29G9
|
Amantadine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Aminosalicylic acid + Mefloquine
|
DCEZ81W
|
Aminosalicylic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Arfolitixorin + Mefloquine
|
DCXMA1O
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Armodafinil + Mefloquine
|
DCDAXT3
|
Armodafinil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Artemether + Mefloquine
|
DC7A9R2
|
Artemether
|
DD2 (Cell Line: DD2)
|
[5] |
Artemether + Mefloquine
|
DCQXXBU
|
Artemether
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
AS602868 + Mefloquine
|
DC7M053
|
AS602868
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Asenapine + Mefloquine
|
DCOJT4E
|
Asenapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Azelnidipine + Mefloquine
|
DC31ZOK
|
Azelnidipine
|
DD2 (Cell Line: DD2)
|
[5] |
Azelnidipine + Mefloquine
|
DCHM2TI
|
Azelnidipine
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Bafilomycin A1 + Mefloquine
|
DCT1CR2
|
Bafilomycin A1
|
DD2 (Cell Line: DD2)
|
[5] |
BGT226 + Mefloquine
|
DC8KOUU
|
BGT226
|
DD2 (Cell Line: DD2)
|
[5] |
BHV-0223 + Mefloquine
|
DCHMUYW
|
BHV-0223
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Bifemelane + Mefloquine
|
DC175SE
|
Bifemelane
|
DD2 (Cell Line: DD2)
|
[5] |
BIIB-021 + Mefloquine
|
DCNM7P1
|
BIIB-021
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Biperiden + Mefloquine
|
DCSYD64
|
Biperiden
|
DD2 (Cell Line: DD2)
|
[5] |
BIX-01294 + Mefloquine
|
DCMEIA2
|
BIX-01294
|
DD2 (Cell Line: DD2)
|
[5] |
BIX-01294 + Mefloquine
|
DCZ51Q1
|
BIX-01294
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Bortezomib + Mefloquine
|
DCOBNMX
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Brincidofovir + Mefloquine
|
DC435EZ
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Buspirone + Mefloquine
|
DCT77RM
|
Buspirone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Carfilzomib + Mefloquine
|
DCHCP60
|
Carfilzomib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Carvedilol + Mefloquine
|
DCZH6RB
|
Carvedilol
|
DD2 (Cell Line: DD2)
|
[5] |
Chlormezanone + Mefloquine
|
DC3PT5N
|
Chlormezanone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Chloroxine + Mefloquine
|
DCYMBL4
|
Chloroxine
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Chloroxine + Mefloquine
|
DCRFFQL
|
Chloroxine
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[5] |
Chlorphenesin + Mefloquine
|
DCZMVK0
|
Chlorphenesin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Cilostazol + Mefloquine
|
DCXSYNS
|
Cilostazol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Citalopram + Mefloquine
|
DCW315W
|
Citalopram
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Clindamycin + Mefloquine
|
DCEW26U
|
Clindamycin
|
DD2 (Cell Line: DD2)
|
[5] |
Clopidogrel + Mefloquine
|
DCFZHZR
|
Clopidogrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Daidzin + Mefloquine
|
DCNUYEK
|
Daidzin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Daporinad + Mefloquine
|
DC6XEKJ
|
Daporinad
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Dasatinib + Mefloquine
|
DCKSUPG
|
Dasatinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Dasatinib + Mefloquine
|
DCXF0BX
|
Dasatinib
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[5] |
Dihydroergotamine + Mefloquine
|
DCEATEO
|
Dihydroergotamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Dihydroergotamine + Mefloquine
|
DCV6JJQ
|
Dihydroergotamine
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Disopyramide + Mefloquine
|
DCWOT08
|
Disopyramide
|
DD2 (Cell Line: DD2)
|
[5] |
Docetaxel + Mefloquine
|
DC2Q3BT
|
Docetaxel
|
DD2 (Cell Line: DD2)
|
[5] |
Dopamine + Mefloquine
|
DCJF0IP
|
Dopamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Doxepin + Mefloquine
|
DCR9A55
|
Doxepin
|
DD2 (Cell Line: DD2)
|
[5] |
Doxycycline + Mefloquine
|
DC60EYZ
|
Doxycycline
|
DD2 (Cell Line: DD2)
|
[5] |
Enalaprilat + Mefloquine
|
DCOAEJN
|
Enalaprilat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Endoxifen + Mefloquine
|
DC0IJ6C
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Entacapone + Mefloquine
|
DCT9PCF
|
Entacapone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Eptifibatide + Mefloquine
|
DCT2C9L
|
Eptifibatide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Estramustine + Mefloquine
|
DCXPN3V
|
Estramustine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Ethambutol + Mefloquine
|
DCK1HUQ
|
Ethambutol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Ethinyl estradiol + Mefloquine
|
DCNN96L
|
Ethinyl estradiol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Everolimus + Mefloquine
|
DCZVM37
|
Everolimus
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Ezetimibe + Mefloquine
|
DCURNS1
|
Ezetimibe
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Fendiline + Mefloquine
|
DCX28PT
|
Fendiline
|
DD2 (Cell Line: DD2)
|
[5] |
Flavonoid derivative 1 + Mefloquine
|
DCL3EWL
|
Flavonoid derivative 1
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Fosfomycin + Mefloquine
|
DCNBG49
|
Fosfomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
GDC-0084 + Mefloquine
|
DCOTCG3
|
GDC-0084
|
DD2 (Cell Line: DD2)
|
[5] |
Gefitinib + Mefloquine
|
DCGA7HL
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Ginsenoside Rb1 + Mefloquine
|
DC0WG15
|
Ginsenoside Rb1
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Gliclazide + Mefloquine
|
DCV9H84
|
Gliclazide
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
GSK2126458 + Mefloquine
|
DCK0ZTL
|
GSK2126458
|
DD2 (Cell Line: DD2)
|
[5] |
GSK618334 + Mefloquine
|
DCLZMZS
|
GSK618334
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Hydralazine + Mefloquine
|
DCLYWF4
|
Hydralazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Hyodeoxycholic acid + Mefloquine
|
DCNPRZP
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Imipramine + Mefloquine
|
DCCPUCJ
|
Imipramine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Isoproterenol + Mefloquine
|
DCD2MY6
|
Isoproterenol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Isosorbide dinitrate + Mefloquine
|
DCC3Q0F
|
Isosorbide dinitrate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Ivermectin + Mefloquine
|
DCXF2SB
|
Ivermectin
|
DD2 (Cell Line: DD2)
|
[5] |
K-134 + Mefloquine
|
DCXANUR
|
K-134
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
KN-62 + Mefloquine
|
DCGXNN9
|
KN-62
|
DD2 (Cell Line: DD2)
|
[5] |
KN-62 + Mefloquine
|
DC5H4D3
|
KN-62
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
L-165041 + Mefloquine
|
DC2ZP2R
|
L-165041
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Lacosamide + Mefloquine
|
DCW3BOR
|
Lacosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Lefaxin + Mefloquine
|
DC7EWLR
|
Lefaxin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Lidoflazine + Mefloquine
|
DC7RHOA
|
Lidoflazine
|
DD2 (Cell Line: DD2)
|
[5] |
Lidoflazine + Mefloquine
|
DC89FCR
|
Lidoflazine
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Linagliptin + Mefloquine
|
DCD0J45
|
Linagliptin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
MANOALIDE + Mefloquine
|
DCM5JM9
|
MANOALIDE
|
DD2 (Cell Line: DD2)
|
[5] |
MANOALIDE + Mefloquine
|
DCR8TH7
|
MANOALIDE
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Maraviroc + Mefloquine
|
DC5GKNZ
|
Maraviroc
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mebendazole + Mefloquine
|
DCLDN5P
|
Mebendazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mebendazole + Mefloquine
|
DCW09SC
|
Mebendazole
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Mebendazole + Mefloquine
|
DCZ6NYQ
|
Mebendazole
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[5] |
Mecamylamine + Mefloquine
|
DC0C4ZD
|
Mecamylamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Aprepitant
|
DCEAOY5
|
Aprepitant
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Meclofenamic acid
|
DCSYOET
|
Meclofenamic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Ribavirin-TP
|
DCF3TRT
|
Ribavirin-TP
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Sertraline
|
DCCA7DP
|
Sertraline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Mebutamate
|
DCTPBE6
|
Mebutamate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Triiodothyronine
|
DCR5DAQ
|
Triiodothyronine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Clindamycin
|
DCNW5EQ
|
Clindamycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Diethylcarbamazine
|
DCGWMDC
|
Diethylcarbamazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + OZ277
|
DC3J9D5
|
OZ277
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + OZ277
|
DC37Z5O
|
OZ277
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Lumefantrine
|
DC3O5Q3
|
Lumefantrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Lumefantrine
|
DCDRBXT
|
Lumefantrine
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Lumefantrine
|
DCANIUA
|
Lumefantrine
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Kanamycin
|
DC4KBHF
|
Kanamycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Dactinomycin
|
DCPGY8I
|
Dactinomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Terazosin
|
DCUAW9Y
|
Terazosin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Tindamax
|
DCV795G
|
Tindamax
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Furazolidone
|
DCO80IV
|
Furazolidone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + GYKI-52466
|
DCL3H9K
|
GYKI-52466
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Artemether
|
DC6FDKN
|
Artemether
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Artemether
|
DCRPIPK
|
Artemether
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Trioxsalen
|
DC0BU5H
|
Trioxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Repaglinide
|
DCOG1OK
|
Repaglinide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Vinblastine
|
DCMZVEX
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Anamorelin
|
DC0WCGZ
|
Anamorelin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Alvespimycin hydrochloride
|
DCD4RTL
|
Alvespimycin hydrochloride
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + MK-3207
|
DCLEOI3
|
MK-3207
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Acitretin
|
DCJSQ00
|
Acitretin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Dexmedetomidine
|
DC92EKF
|
Dexmedetomidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Tranexamic acid
|
DCGVL4K
|
Tranexamic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + 10-hydroxycamptothecin
|
DC2FO6C
|
10-hydroxycamptothecin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Azelnidipine
|
DCKQBHT
|
Azelnidipine
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Azelnidipine
|
DCZV3W0
|
Azelnidipine
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Diltiazem
|
DCM99AW
|
Diltiazem
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Diltiazem
|
DC4BX3B
|
Diltiazem
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Pamidronate
|
DC4HWKK
|
Pamidronate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Palonosetron
|
DCUCK4T
|
Palonosetron
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Testosterone cypionate
|
DC86WP6
|
Testosterone cypionate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Guanfacine
|
DCSWHYJ
|
Guanfacine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Cinacalcet
|
DCW46P3
|
Cinacalcet
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Carglumic acid
|
DC60FAW
|
Carglumic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Chlorzoxazone
|
DCJQZ1I
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + ETHISTERONE
|
DCWTLTM
|
ETHISTERONE
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Cilastatin
|
DC69FN6
|
Cilastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Galantamine
|
DCA9AOL
|
Galantamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + JZL195
|
DC918YN
|
JZL195
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Pazopanib
|
DC4C7KQ
|
Pazopanib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Phensuximide
|
DCE6YJW
|
Phensuximide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Fibrates
|
DCOZE6E
|
Fibrates
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + WAY-100635
|
DCX9LDU
|
WAY-100635
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Armodafinil
|
DCUY7F5
|
Armodafinil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Ciprofibrate
|
DC97GFD
|
Ciprofibrate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Mifepristone
|
DC7JE6B
|
Mifepristone
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Mefloquine + Pentamidine
|
DCM3A5M
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + PFK-158
|
DCN10DO
|
PFK-158
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Sulfapyridine
|
DCTSQ20
|
Sulfapyridine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Niclosamide
|
DCB98HQ
|
Niclosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Eflornithine
|
DCO3RTB
|
Eflornithine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + PF-02545920
|
DCUG7BU
|
PF-02545920
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Norcisapride
|
DCI2KTB
|
Norcisapride
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Etonogestrel
|
DCWITE8
|
Etonogestrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Oseltamivir
|
DC5WC0T
|
Oseltamivir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Ibutilide
|
DCG9ZH7
|
Ibutilide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Diazoxide
|
DCJY4N8
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Tamoxifen
|
DCM84H1
|
Tamoxifen
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Mefloquine + Tamoxifen
|
DCPMOSD
|
Tamoxifen
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[5] |
Mefloquine + KN-62
|
DC4OXL1
|
KN-62
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Pargyline
|
DCPC4GY
|
Pargyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Idarubicin
|
DCI2AG9
|
Idarubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Epothilone B
|
DCLFS4N
|
Epothilone B
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + BRL-15572
|
DCK6VOQ
|
BRL-15572
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + GSK2126458
|
DCXDW60
|
GSK2126458
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Imatinib
|
DCU3WD2
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Probenecid
|
DCR7X1M
|
Probenecid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Darunavir
|
DCTMW9M
|
Darunavir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Pramipexole
|
DCQDPEC
|
Pramipexole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Methylene blue
|
DC8251O
|
Methylene blue
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Methylene blue
|
DC3CKTO
|
Methylene blue
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Moricizine
|
DCBFEPM
|
Moricizine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Artemisinin
|
DC055CK
|
Artemisinin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Artemisinin
|
DC6XUXQ
|
Artemisinin
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Olanzapine
|
DC4BWDZ
|
Olanzapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Clascoterone
|
DC9RYA8
|
Clascoterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Cefmenoxime
|
DC0B7CK
|
Cefmenoxime
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Trimethobenzamide
|
DCJ7RBK
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Omacetaxine mepesuccinate
|
DCJY0XJ
|
Omacetaxine mepesuccinate
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Omacetaxine mepesuccinate
|
DCDJJ89
|
Omacetaxine mepesuccinate
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Maprotiline
|
DCP1GBQ
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Teriflunomide
|
DCZY87T
|
Teriflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Acetohexamide
|
DC0MOJV
|
Acetohexamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Chlorambucil
|
DCTLSJ8
|
Chlorambucil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Brincidofovir
|
DCE1D59
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Sorafenib
|
DCF0PRY
|
Sorafenib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Desoxycorticosterone pivalate
|
DCGD429
|
Desoxycorticosterone pivalate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Prazosin
|
DCFTUOE
|
Prazosin
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Mefloquine + Chloroquine
|
DC9UL52
|
Chloroquine
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Asenapine
|
DC8XGER
|
Asenapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Piperaquine
|
DC6YLK3
|
Piperaquine
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Piperaquine
|
DCNO7DQ
|
Piperaquine
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + NVP-AUY922
|
DCOM1R3
|
NVP-AUY922
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + NVP-AUY922
|
DC1W540
|
NVP-AUY922
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Mycophenolic acid
|
DCRE9FG
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Oxandrolone
|
DCH8BCZ
|
Oxandrolone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + JTC-801
|
DC44JIW
|
JTC-801
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Silver sulfadiazine
|
DCIJD2B
|
Silver sulfadiazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Olmesartan medoxomil
|
DCTTEBR
|
Olmesartan medoxomil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + PPADS
|
DCS0LYF
|
PPADS
|
DD2 (Cell Line: DD2)
|
[5] |
Mefloquine + Metaxalone
|
DCUF7FS
|
Metaxalone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Busulfan
|
DC1IRCH
|
Busulfan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Atovaquone
|
DC7AZC0
|
Atovaquone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Atovaquone
|
DCM662B
|
Atovaquone
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Mefloquine + Aciclovir
|
DCO9JL1
|
Aciclovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Enoxacin
|
DCLJ4W0
|
Enoxacin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Raltegravir
|
DC4KDHN
|
Raltegravir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Albendazole
|
DCFU6M1
|
Albendazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mefloquine + Tetracycline
|
DCPULF5
|
Tetracycline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Mephenytoin + Mefloquine
|
DCHMWKN
|
Mephenytoin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Metformin + Mefloquine
|
DCCVZ4F
|
Metformin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Methocarbamol + Mefloquine
|
DCVTY29
|
Methocarbamol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Methoxsalen + Mefloquine
|
DC1JUMW
|
Methoxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Metyrosine + Mefloquine
|
DCHA8XD
|
Metyrosine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Miconazole + Mefloquine
|
DCI5Q59
|
Miconazole
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Midostaurin + Mefloquine
|
DCVVVOY
|
Midostaurin
|
DD2 (Cell Line: DD2)
|
[5] |
Midostaurin + Mefloquine
|
DC40MCL
|
Midostaurin
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Miglustat + Mefloquine
|
DC07YUW
|
Miglustat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
MK-3207 + Mefloquine
|
DCO9CWU
|
MK-3207
|
DD2 (Cell Line: DD2)
|
[5] |
MK-3207 + Mefloquine
|
DCSYGJS
|
MK-3207
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
ML323 + Mefloquine
|
DCAI9KV
|
ML323
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Nabilone + Mefloquine
|
DCRX2DW
|
Nabilone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Naftopidil + Mefloquine
|
DCTDB4W
|
Naftopidil
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Naltrexone + Mefloquine
|
DCX4YJK
|
Naltrexone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Naringenin + Mefloquine
|
DC6UP7U
|
Naringenin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Nitisinone + Mefloquine
|
DC3JM7R
|
Nitisinone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Nitisinone + Mefloquine
|
DCPXX4B
|
Nitisinone
|
DD2 (Cell Line: DD2)
|
[5] |
Nitisinone + Mefloquine
|
DC7O0C4
|
Nitisinone
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Nitrosoglutathione + Mefloquine
|
DCJAU4N
|
Nitrosoglutathione
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Nizatidine + Mefloquine
|
DCLK2GV
|
Nizatidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Novobiocin + Mefloquine
|
DC32WOL
|
Novobiocin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Omacetaxine mepesuccinate + Mefloquine
|
DC7PHFF
|
Omacetaxine mepesuccinate
|
DD2 (Cell Line: DD2)
|
[5] |
Omacetaxine mepesuccinate + Mefloquine
|
DCBQ31L
|
Omacetaxine mepesuccinate
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Otilonium bromide + Mefloquine
|
DC1JO3F
|
Otilonium bromide
|
DD2 (Cell Line: DD2)
|
[5] |
Otilonium bromide + Mefloquine
|
DC1MFKQ
|
Otilonium bromide
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Panobinostat + Mefloquine
|
DC73SKF
|
Panobinostat
|
DD2 (Cell Line: DD2)
|
[5] |
Panobinostat + Mefloquine
|
DC9J3LU
|
Panobinostat
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Paromomycin + Mefloquine
|
DC43V13
|
Paromomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Parthenolide + Mefloquine
|
DCBPDHS
|
Parthenolide
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Pentamidine + Mefloquine
|
DCVFQAL
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Pentostatin + Mefloquine
|
DCG20FA
|
Pentostatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
PHA-739358 + Mefloquine
|
DCNYP4X
|
PHA-739358
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Phenprocoumon + Mefloquine
|
DCX35IZ
|
Phenprocoumon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Picoplatin + Mefloquine
|
DCDXB0F
|
Picoplatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Pizotyline + Mefloquine
|
DCXSAH9
|
Pizotyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
PMID28460551-Compound-2 + Mefloquine
|
DCM5F1W
|
PMID28460551-Compound-2
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Pomalidomide + Mefloquine
|
DCH4WUC
|
Pomalidomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Pramipexole + Mefloquine
|
DCO21AF
|
Pramipexole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Pyronaridine + Mefloquine
|
DCC23NU
|
Pyronaridine
|
DD2 (Cell Line: DD2)
|
[5] |
Pyronaridine + Mefloquine
|
DCCW723
|
Pyronaridine
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Quinine + Mefloquine
|
DCLORWH
|
Quinine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Quinine + Mefloquine
|
DCFIEDB
|
Quinine
|
DD2 (Cell Line: DD2)
|
[5] |
Quinine + Mefloquine
|
DCKQH8W
|
Quinine
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Ramelteon + Mefloquine
|
DCNBQXV
|
Ramelteon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Rifampin + Mefloquine
|
DCZ397W
|
Rifampin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Ritonavir + Mefloquine
|
DC9O4OW
|
Ritonavir
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Sarpogrelate + Mefloquine
|
DCM3YVP
|
Sarpogrelate
|
DD2 (Cell Line: DD2)
|
[5] |
Sitagliptin + Mefloquine
|
DCONIPB
|
Sitagliptin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Sitosterol + Mefloquine
|
DCI36WZ
|
Sitosterol
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
SNDX-275 + Mefloquine
|
DCPC8F8
|
SNDX-275
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
SNS-032 + Mefloquine
|
DC2Q6CM
|
SNS-032
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
Sorafenib + Mefloquine
|
DCU9GQS
|
Sorafenib
|
DD2 (Cell Line: DD2)
|
[5] |
Sorafenib + Mefloquine
|
DCXVF3T
|
Sorafenib
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Spironolactone + Mefloquine
|
DCCFANV
|
Spironolactone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Strontium ranelate + Mefloquine
|
DCLLO1O
|
Strontium ranelate
|
DD2 (Cell Line: DD2)
|
[5] |
Sulfinpyrazone + Mefloquine
|
DCCM02Q
|
Sulfinpyrazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Sumatriptan + Mefloquine
|
DCAPLWU
|
Sumatriptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Tacrine + Mefloquine
|
DC7CKJI
|
Tacrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Tamoxifen + Mefloquine
|
DC3Y12V
|
Tamoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Testosterone + Mefloquine
|
DC8VEW6
|
Testosterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Tetrandrine + Mefloquine
|
DCVLSWH
|
Tetrandrine
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
THAPSIGARGIN + Mefloquine
|
DCMTDJ0
|
THAPSIGARGIN
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[5] |
THAPSIGARGIN + Mefloquine
|
DCA718A
|
THAPSIGARGIN
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[5] |
Theophylline + Mefloquine
|
DCXI7BY
|
Theophylline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Thiolactomycin + Mefloquine
|
DC4AC75
|
Thiolactomycin
|
DD2 (Cell Line: DD2)
|
[5] |
Thiolactomycin + Mefloquine
|
DCKKKQ0
|
Thiolactomycin
|
Hepatoblastoma (Cell Line: HB3)
|
[6] |
Tiagabine + Mefloquine
|
DCUG2ZJ
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Tolazoline + Mefloquine
|
DCIUT34
|
Tolazoline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Tolvaptan + Mefloquine
|
DCQBLXF
|
Tolvaptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Topotecan + Mefloquine
|
DC2WBD4
|
Topotecan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[6] |
Trametinib + Mefloquine
|
DC8K9SY
|
Trametinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[6] |
Triamterene + Mefloquine
|
DCYQVY2
|
Triamterene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Trichostatin A + Mefloquine
|
DCYUDT5
|
Trichostatin A
|
DD2 (Cell Line: DD2)
|
[5] |
Trifluoperazine + Mefloquine
|
DCBV1HA
|
Trifluoperazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Triflupromazine + Mefloquine
|
DC804QN
|
Triflupromazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Ursodeoxycholic acid + Mefloquine
|
DCL8YZQ
|
Ursodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Verapamil + Mefloquine
|
DCVIJ4O
|
Verapamil
|
DD2 (Cell Line: DD2)
|
[6] |
Vorinostat + Mefloquine
|
DCXRP99
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
Vorinostat + Mefloquine
|
DCTPO49
|
Vorinostat
|
Hepatoblastoma (Cell Line: HB3)
|
[5] |
Zileuton + Mefloquine
|
DCUN3GM
|
Zileuton
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[5] |
ZM-447439 + Mefloquine
|
DC4R0IA
|
ZM-447439
|
DD2 (Cell Line: DD2)
|
[5] |
------------------------------------------------------------------------------------ |
|
|
|
|